HomeInsights52 Week High Stocks

Medicamen Biotech Ltd 52 Week High

Medicamen Biotech Ltd 52 Week High

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

10.5 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Medicamen Biotech Ltd

NSE: MEDICAMEQ

YEARHIGH

₹ 655

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week HIGH of Medicamen Biotech Ltd is ₹ 655 as of 22 Nov 24 .

Company Fundamentals for Medicamen Biotech Ltd

No data available

Market Price of Medicamen Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Medicamen Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024448.05
21 Nov 2024431.4
19 Nov 2024449.1
18 Nov 2024463.2
14 Nov 2024450.8
13 Nov 2024456.65
12 Nov 2024481.1
11 Nov 2024489.95
08 Nov 2024506.7
07 Nov 2024517.45

Asset Value vs Market Value of Medicamen Biotech Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Medicamen Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Medicamen Biotech Ltd

No data available

* All values are in crore

Medicamen Biotech Ltd News Hub

News

Medicamen Biotech declare Quarterly Result

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 14 Novem...

Read more

08 Nov 202412:28

News

Medicamen Biotech to conduct AGM

Medicamen Biotech announced that the Annual General Meeting (AGM) of the company will be h...

Read more

13 Sep 202411:43

News

Medicamen Biotech to conduct board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 13 Augus...

Read more

12 Aug 202410:31

News

Board of Medicamen Biotech recommends Final Dividend

Medicamen Biotech announced that the Board of Directors of the Company at its meeting held...

Read more

29 May 202417:32

News

Medicamen Biotech schedules board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 29 May 2...

Read more

25 May 202415:28

News

Medicamen Biotech to conduct board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 12 Febru...

Read more

06 Feb 202414:01

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Medicamen Biotech Ltd

What is the significance of Medicamen Biotech Ltd reaching its 52-week high?

Medicamen Biotech Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Medicamen Biotech Ltd 52-week high?

Investors monitor Medicamen Biotech Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Medicamen Biotech Ltd a good buy when it hits its 52-week high?

Whether Medicamen Biotech Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Medicamen Biotech Ltd fundamentals.

What should I consider before investing in Medicamen Biotech Ltd at its 52-week high?

Before investing in Medicamen Biotech Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Medicamen Biotech Ltd stock price continue to rise after reaching its 52-week high?

Medicamen Biotech Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*